Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1974 Dec;1(6):485–489. doi: 10.1111/j.1365-2125.1974.tb01698.x

The effect of frusemide on indomethacin plasma levels

P M Brooks, M A Bell, P Lee, P J Rooney, W C Dick
PMCID: PMC1402534  PMID: 22454934

Abstract

1 The pharmacokinetic and clinical effects of concurrent oral indomethacin and frusemide administration were determined in eight patients with rheumatoid arthritis.

2 Oral frusemide significantly reduces the plasma level of indomethacin following concurrent administration of the two drugs orally.

3 A profile of pain index, articular index and grip strength following oral indomethacin (50 mg) was determined and although the decrease in articular index was less when frusemide and indomethacin were given together it did not reach statistical significance.

Full text

PDF
485

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Champion G. D., Paulus H. E., Mongan E., Okun R., Pearson C. M. The effect of aspirin on serum indomethacin. Clin Pharmacol Ther. 1972 Mar-Apr;13(2):239–244. doi: 10.1002/cpt1972132239. [DOI] [PubMed] [Google Scholar]
  2. DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association. Ann Rheum Dis. 1959 Mar;18(1):49–53. [PMC free article] [PubMed] [Google Scholar]
  3. Emori H. W., Champion G. D., Bluestone R., Paulus H. E. Simultaneous pharmacokinetics of indomethacin in serum and synovial fluid. Ann Rheum Dis. 1973 Sep;32(5):433–435. doi: 10.1136/ard.32.5.433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Forrey A. W., Kimpel B., Blair A. D., Cutler R. E. Furosemide concentrations in serum and urine, and its binding by serum proteins as measured fluorometrically. Clin Chem. 1974 Feb;20(2):152–158. [PubMed] [Google Scholar]
  5. Hvidberg E., Lausen H. H., Jansen J. A. Indomethacin: plasma concentrations and protein binding in man. Eur J Clin Pharmacol. 1972 Mar;4(2):119–124. doi: 10.1007/BF00562508. [DOI] [PubMed] [Google Scholar]
  6. Kelly M. R., Cutler R. E., Forrey A. W., Kimpel B. M. Pharmacokinetics of orally administered furosemide. Clin Pharmacol Ther. 1974 Feb;15(2):178–186. [PubMed] [Google Scholar]
  7. Lee P., Ahola S. J., Grennan D., Brooks P., Buchanan W. W. Observations on drug prescribing in rheumatoid arthritis. Br Med J. 1974 Mar 9;1(5905):424–426. doi: 10.1136/bmj.1.5905.424. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Lee P., Baxter A., Dick W. C., Webb J. An assessment of grip strength measurement in rheumatoid arthritis. Scand J Rheumatol. 1974;3(1):17–23. doi: 10.3109/03009747409165124. [DOI] [PubMed] [Google Scholar]
  9. Lee P., Webb J., Anderson J., Buchanan W. W. Method for assessing therapeutic potential of anti-inflammatory antirheumatic drugs in rheumatoid arthritis. Br Med J. 1973 Jun 23;2(5868):685–688. doi: 10.1136/bmj.2.5868.685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ritchie D. M., Boyle J. A., McInnes J. M., Jasani M. K., Dalakos T. G., Grieveson P., Buchanan W. W. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med. 1968 Jul;37(147):393–406. [PubMed] [Google Scholar]
  11. Skeith M. D., Simkin P. A., Healey L. A. The renal excretion of indomethacin and its inhibition by probenecid. Clin Pharmacol Ther. 1968 Jan-Feb;9(1):89–93. doi: 10.1002/cpt19689189. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES